OSTTF yields 0.57% · PFE yields 6.13%● Live data
📍 OSTTF pulled ahead of the other in Year 1
Combined, OSTTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OSTTF + PFE for your $10,000?
OSAKA Titanium technologies Co.,Ltd. manufactures and sells titanium products. The company offers titanium sponges, titanium ingots, titanium tetrachloride, titanium tetrachloride aqueous solutions, and ferro-titanium products; and high-purity titanium, silicon monoxide, and photocatalysts, as well as gas-atomized titanium powder and titanium hydride-dehydride powder. Its products are used in various applications, such as aircraft engine components, power plants, petrochemical and seawater desalination plants, and sheets for heat exchangers used in ships and LNG manufacturing plants; medical parts, packaging materials, negative electrode materials, sintered parts, personal computers, tablets/smartphones, and liquid crystal televisions; digital home appliances; and semiconductors and other materials in the electronics industry. The company was formerly known as Sumitomo Titanium Corporation and changed its name to OSAKA Titanium technologies Co.,Ltd. in 2007. OSAKA Titanium technologies Co.,Ltd. was founded in 1952 and is headquartered in Amagasaki, Japan.
Full OSTTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.